🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi’an
Clinical trial register · China

Clinical Trials in Xi’an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital124 Tang-Du Hospital49 First Affiliated Hospital Xi'an Jiaotong University41 Air Force Military Medical University, China19 Xijing Hospital of Digestive Diseases19
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Xi’an

504 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
NCT07410507Schizophrenia
Eli Lilly and Company
Phase 2
450
Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian
2026-02-10
Recruiting
Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke
NCT07405762Ischemic Stroke
Xijing Hospital
Observational
180
Xi'an
2026-02-05
Recruiting
Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Low Back Pain (LBP) in Adults
NCT07368920Low Back Pain, Paraspinal Muscles, CLBP - Chronic Low Back Pain
Xijing Hospital
Not applicable
40
Xi'an
2026-02-01
Not yet open
Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma
NCT06952621Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital
Phase 3
390
Xi'an
2026-02-01
Recruiting
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
NCT07383818HR Positive/HER2 Low Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
111
Harbin, Hefei, Shanghai, Xi'an, Zhengzhou
2026-02-01
Active, closed
Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure
NCT07519005Hepatic Failure
Xijing Hospital
Phase EARLY_PHASE1
1
Xi'an
2026-01-31
Recruiting
Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients
NCT07365345Transcatheter Aortic Valve Replacement (TAVR), Hemodynamic Stability, Anesthesia Induction, Electro-acupuncture
Air Force Military Medical University, China
Not applicable
150
Xi'an
2026-01-30
Recruiting
A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC
NCT07385001Esophageal Squamous Cell Carcinoma, Ivonescimab, Neoadjuvant
Tang-Du Hospital
Phase 1/2
45
Xi'an
2026-01-28
Active, closed
Time-Restricted Eating for Weight-Loss Maintenance
NCT07163455Overweight or Obese Adults
Harbin Medical University
Not applicable
500
Beijing, Chongqing, Shenzhen, Harbin, Xi'an, Qingdao, Weifang, Chengdu
2026-01-26
Recruiting
Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial
NCT07498374Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
Tang-Du Hospital
Not applicable
192
Xi'an
2026-01-21
Not yet open
Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study
NCT07307534Vitiligo, Halo Nevus
Xijing Hospital
Not applicable
60
Xi'an
2026-01-20
Active, closed
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
NCT07230860Dermatitis, Atopic
Janssen Research & Development, LLC
Phase 2
189
Beijing, Changsha, Chengde, Chengdu, Guangzhou, Sanmenxia, Wuxi, Xi'an
2026-01-20
Recruiting
Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy
NCT07365267Breast Cancer, Breast Reconstruction After Mastectomy, 3D-Printed Biodegradable Biological Mesh
Xijing Hospital
Not applicable
25
Xi'an
2026-01-15
Recruiting
The Optimal Measurement Time for the New Gallbladder Function Assessment Method
NCT07321431Gallbladder; Functional Disturbance
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
120
Lanzhou, Qinhuangdao, Shenyang, Yinchuan, Xi’an
2026-01-07
Recruiting
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled Study
NCT07454070Depressive Disorder (Per DSM-V Criteria, Mild-to-moderate), Acute Coronary Syndrome (ACS), Percutaneous Coronary Intervention (PCI), Depressive Disorder
Jing Han
Not applicable
120
Xi'an
2026-01-06
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
By invitation
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
NCT07352228Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol
Xijing Hospital
Phase 4
350
Xi'an
2026-01-01
Not yet open
Multicenter RCT: LED Red Light Dose-Response in Myopia Progression Control
NCT07330180Myopia, Myopia, Progressive
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
364
Chongqing, Foshan, Zhengzhou, Wuhan, Shenyang, Guilin, Xi’an
2026-01-01
Recruiting
Safety and Efficacy Analysis of Stent-assisted Coil Embolization in the Treatment of Acute Ruptured Intracranial Aneurysms in the Perioperative Period.
NCT07683377Ruptured Aneurysm of Intracranial Artery, Stent-Assisted Coiling, Efficacy and Safety
Tang-Du Hospital
Not applicable
174
Xi'an
2026-01-01
Recruiting
Efficacy and Safety of Variceal Embolization Combined With Partial Splenic Artery Embolization for Variceal Bleeding in Cavernous Transformation of Portal Vein.
NCT07310316Cavernous Transformation of Portal Vein, Gastroesophageal Varices Bleeding
Air Force Military Medical University, China
Not applicable
26
Xi'an
2026-01-01
Not yet open
Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification
NCT07199101Radiation Dose Reduction
Beijing Children's Hospital
Not applicable
2,650
Beijing, Chongqing, Guangzhou, Baoding, Zhengzhou, Wuxi, Changchun, Xi'an
2026-01-01
Active, closed
Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer
NCT07498400Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Cancer
Xijing Hospital
Not applicable
216
Xi'an
2026-01-01
Not yet open
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
NCT07168291Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma ( FL), Burkitt Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1
3
Xi'an
2025-12-31
Recruiting
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
NCT07274813Advanced/Metastatic Solid Tumors, NSCLC
Shanghai Henlius Biotech
Phase EARLY_PHASE1
254
Shanghai, Xi'an
2025-12-29
By invitation
Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD
NCT07475052Inflammatory Bowel Disease, Heart Rate Variability, Biologics, Prediction
Xijing Hospital
Observational
100
Xi'an
2025-12-25
Not yet open
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551Vitiligo
Xijing Hospital
Observational
125
Xi'an
2025-12-23
Recruiting
Anxiety and Depression in IBS: A Brain-Gut Axis Study
NCT07646834Irritable Bowel Syndrome (IBS), Anxiety, Depression
Tang-Du Hospital
Observational
200
Xi'an
2025-12-21
Recruiting
Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
NCT07022587De Novo Stenosis, Coronary Artery Disease
Xijing Hospital
Not applicable
2,000
Xi'an
2025-12-20
Recruiting
Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)
NCT07263919Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Akeso
Phase 2
90
Xi'an
2025-12-19
Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
NCT07127822Gastric / Gastroesophageal Junction Adenocarcinoma, MSI-H Cancer
Peking University
Phase 2
106
Shijiazhuang, Harbin, Zhengzhou, Nanjing, Xi'an, Qingdao, Taiyuan, Chengdu
2025-12-15
Recruiting
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
NCT07296458Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases
Phase 3
132
Xi'an
2025-12-15
Recruiting
Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)
NCT07262645Alzheimer s Disease
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-15
Recruiting
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer
NCT07569679Biliary Tract Cancer
Air Force Military Medical University, China
Phase 2
124
Xi'an
2025-12-10
Recruiting
A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT07294625Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
36
Zhengzhou, Nanjing, Xuzhou, Shanghai, Xi’an
2025-12-10
Recruiting
A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
NCT07179679Multiple Myeloma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
42
Chongqing, Guangzhou, Chengde, Tangshan, Nanjing, Suzhou, Nanchang, Xi'an
2025-12-09
Recruiting
Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07377305NMO Spectrum Disorder
Tang-Du Hospital
Not applicable
12
Xi'an
2025-12-08
Recruiting
Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy
NCT07266181Refractory Membranous Nephropathy
The First Affiliated Hospital of Air Force Medicial University
Phase 1
5
Xi'an
2025-12-08
Recruiting
Atosiban in Women With Previous Implantation Failure and Abnormal Uterine Contractions
NCT07185230Infertility
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Not applicable
792
Xi'an
2025-12-06
By invitation
Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas
NCT07448233Epilepsies, Remote Management of Epilepsy in Rural Areas
Xijing Hospital
Not applicable
20
Xi'an
2025-12-01
Not yet open
Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid Microcarcinoma
NCT07249125Papillary Thyroid Microcarcinoma
Xijing Hospital
Observational
1,630
Xi'an
2025-12-01
Recruiting
A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis
NCT07780929Psoriasis, Psoriasis (PsO)
Xijing Hospital
Not applicable
5
Xi'an
2025-11-17
Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803Atopic Dermatitis
Sanofi
Observational
1,000
Beijing, Shenzhen, Changsha, Xi’an, Chengdu, Hangzhou, Ningbo, Chongqing
2025-11-17
Recruiting
A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
NCT07178171TNBC, Triple Negative Breast Cancer
Xijing Hospital
Phase 1
30
Xi'an
2025-11-06
Recruiting
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
NCT07108283Nonsegmental Vitiligo
Takeda
Phase 2
200
Wuhan, Xi'an, Shanghai, Kunming, Hangzhou
2025-11-03
Recruiting
Postoperative Delirium in Patients Undergoing Cardiac Surgery
NCT07239648Postoperative Delirium
Xijing Hospital
Observational
1,500
Xi'an
2025-10-31
Recruiting
Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC
NCT07796113Esophageal Squamous Cell Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase 2
24
Xi'an
2025-10-30
Recruiting
A Study of Ivonescimab in First-Line ES-SCLC
NCT07245446Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso
Phase 2
180
Beijing, Xi'an, Shanghai
2025-10-29
Recruiting
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
NCT07139366Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer
Yongquan Shi
Phase 4
1,248
Xi'an
2025-10-28
Recruiting
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
NCT07217067Atrial Fibrillation
Novartis Pharmaceuticals
Phase 2
165
Beijing, Xi'an
2025-10-28
Recruiting
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
NCT07272434Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company
Phase 3
25,000
Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Xi'an, Jinan, Chengdu
2025-10-22
Active, closed
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT07185776Lipoprotein Disorder
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
203
Xi’an
2025-10-21
Recruiting
Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis
NCT07253389Liver Cirrhosis, Gastroesophageal Varices Bleeding
Air Force Military Medical University, China
Not applicable
648
Xi'an
2025-10-20
Recruiting
Desflurane vs. Propofol for Cardiac Anesthesia
NCT07116733Cardiac Surgery, Coronary Artery Bypass Grafting
Xijing Hospital
Phase 3
3,560
Fuzhou, Cangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjin, Xi'an, Chengdu
2025-10-20
Recruiting
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
NCT07140913Mania, Bipolar Disorder
Bristol-Myers Squibb
Phase 3
424
Beijing, Guangzhou, Baoding, Shijiazhuang, Nanjing, Xi'an, Chengdu, Tianjin
2025-10-08
Recruiting
A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis
NCT07270003Palmoplantar Pustulosis (PPP)
Xijing Hospital
Not applicable
60
Xi'an
2025-10-01
Not yet open
Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes
NCT07198932Type 2 Diabetes
Yanbing Li
Observational
594
Hangzhou, Baoding, Beijing, Shanghai, Xi'an
2025-10-01
Not yet open
Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer
NCT07162259Breast Neoplasms
Yan Xue
Phase 4
40
Xi'an
2025-10-01
Recruiting
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
NCT07182890Functional Dyspepsia, Probiotics, Depression, Anxiety
Xijing Hospital of Digestive Diseases
Phase 4
180
Xi’an
2025-09-20
Recruiting
Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
NCT07187492Functional Dyspepsia, Probiotics, Depression, Anxiety
Xijing Hospital of Digestive Diseases
Phase 4
180
Xi’an
2025-09-20
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx
Phase 3
160
Fuzhou, Guangzhou, Beijing, Xi'an
2025-09-16
Not yet open
Multicenter Validation Study on Autism Screening Using a Machine-assisted System
NCT07006948Autism Spectrum Disorder, Early Developmental Impairment, Language Development Disorders
Children's Hospital of Fudan University
Observational
1,000
Hefei, Xiamen, Liuzhou, Harbin, Kunshan, Xi'an, Shanghai, Chengdu
2025-09-15
Recruiting
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382Plaque Psoriasis
Chipscreen Biosciences, Ltd.
Phase 1/2
220
Beijing, Chengde, Shijiazhuang, Shiyan, Jinan, Taiyuan, Xi’an, Hangzhou
2025-09-08
Recruiting
Optimization of taVNS Intervention Strategies for Refractory Constipation
NCT07344402Refractory Constipation
Xijing Hospital of Digestive Diseases
Not applicable
100
Xi'an
2025-09-01
Not yet open
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
NCT07156656Type A Aortic Dissection, Organ Failure, Multiple
Shanghai Zhongshan Hospital
Phase 4
236
Hefei, Fuzhou, Guangzhou, Shenzhen, Xi'an, Shanghai
2025-09-01
Not yet open
Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock
NCT07129031Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)
Xijing Hospital
Phase 3
180
Xi'an
2025-09-01
Recruiting
Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility
NCT07494877Infertility
Tang-Du Hospital
Observational
300
Xi'an
2025-09-01
Not yet open
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
NCT05155358Heat Stroke, Early Waking, MODS, Proteinosis
Xijing Hospital
Observational
150
Xi'an
2025-08-31
Not yet open
A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma
NCT07090954Multiple Myeloma
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1/2
32
Shanghai, Xi'an
2025-08-31
Recruiting
Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
NCT07095790Mild Stroke
Second Affiliated Hospital of Soochow University
Phase 4
580
Suzhou, Shijiazhuang, Zhoukou, Bayan Nur, Huai'an, Suqian, Taizhou, Xi'an
2025-08-30
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
NCT07096843Primary Membranous Nephropathy
Climb Bio, Inc.
Phase 2
45
Beijing, Shenzhen, Wuxi, Xi'an, Jinan, Yantai, Yibin
2025-08-25
Recruiting
Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
NCT07141264SCLC,Extensive Stage
Tang-Du Hospital
Phase 2
32
Xi'an
2025-08-25
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Beijing, Beijin, Guangzhou, Wuhan, Xi'an
2025-08-21
Recruiting
Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic Symptom Disorder
NCT07323407Functional Constipation (FC), Somatic Symptom Disorder (DSM-5), Refractory Constipation
Xijing Hospital of Digestive Diseases
Not applicable
60
Xi'an
2025-08-20
Recruiting
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
NCT07378137Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
NCT07378163Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Not yet open
Prizvalve Transcatheter Aortic Valve in Failing Bioprosthetic Valves
NCT07122050Failing Bioprosthetic Valves
Xijing Hospital
Not applicable
140
Xi'an
2025-08-15
Not yet open
Temporal Interference for Temporal Lobe Epilepsy Under SEEG
NCT07082101Epilepsy
Xijing Hospital
Not applicable
10
Xi'an
2025-08-15
Recruiting
Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06775782Acute Ischemic Stroke
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,150
Xi'an
2025-08-10
Recruiting
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
NCT07141303Acute Ischemic Stroke
Tang-Du Hospital
Phase 3
1,060
Xi'an
2025-08-08
Recruiting
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT07093411B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory
Beijing GoBroad Hospital
Phase EARLY_PHASE1
48
Hefei, Xi'an, Xuzhou
2025-08-05
Recruiting
Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke
NCT06639360Ischemic Stroke, Acute, Endovascular Thrombectomy
Xijing Hospital
Not applicable
60
Xi'an
2025-08-02
Recruiting
Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
NCT07114159Ulcerative Colitis
Xijing Hospital
Not applicable
15
Xi'an
2025-08-02
Not yet open
Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
NCT07129161Carcinoma, Non-Small-Cell Lung
Sun Yat-sen University
Phase 2
66
Guangzhou, Xi'an
2025-08
Not yet open
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
NCT07086326NSCLC, Neoadjuvant Therapy, Immunotherapy, AK112
Yang Fan, MD
Phase 2
164
Beijing, Changsha, Shanghai, Xi’an, Hangzhou
2025-07-31
By invitation
3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL)
NCT07398911Aortic Regurgitation
Xijing Hospital
Not applicable
354
Xi’an
2025-07-30
Recruiting
Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery
NCT06482749Older Patients, Cognitive Impairment, Repetitive Transcranial Magnetic Stimulation, Delayed Neurocognitive Recovery
Peking University First Hospital
Not applicable
568
Beijing, Shenzhen, Xi'an
2025-07-28
Recruiting
A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery
NCT07071402Breast Cancer (Early Breast Cancer)
Xijing Hospital
Not applicable
120
Xi'an
2025-07-18
Recruiting
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
NCT06929273Bipolar Disorder Type I With Mania
Bristol-Myers Squibb
Phase 3
450
Beijing, Guangzhou, Baoding, Changsha, Nanjing, Xi'an, Chengdu, Tianjin
2025-07-18
Recruiting
A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer
NCT07198659Unresectable Pancreatic Cancer
The First Affiliated Hospital of Air Force Medicial University
Phase EARLY_PHASE1
3
Xi’an
2025-07-14
Recruiting
MITRIS China Post Market Clinical Follow-up (PMCF) Study
NCT07059793Mitral Valve Replacement
Edwards Lifesciences
Observational
250
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Nanjing, Xi'an, Jinan
2025-07-08
Recruiting
Rectal NSAIDs With/Without PD Stent for PEP Prevention
NCT07117318Post-ERCP Acute Pancreatitis, Non-steroid Anti-inflammatory Drugs, Pancreatic Duct Stent Placement
Air Force Military Medical University, China
Not applicable
1,278
Beijing, Chongqing, Xiamen, Harbin, Kaifeng, Wuhan, Changsha, Xi'an
2025-07-01
Recruiting
Orthodontic Treatment on Oral Microbiota and Salivary Proteins
NCT06824493Orthodontics, White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, Caries, Dental
Xi'an Jiaotong University
Observational
150
Xi'an
2025-07-01
Recruiting
Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
NCT07584291Melanoma (Skin Cancer)
Xijing Hospital
Observational
200
Xi'an
2025-07-01
By invitation
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
NCT07023965Peripheral Arterial Disease(PAD), Arterial Occlusive Disease, Arteriosclerosis Obliterans, Thromboangiitis Obliterans
Beijing Northland Biotech. Co., Ltd.
Observational
542
Beijing, Chifeng, Dalian, Hangzhou, Xi'an
2025-06-30
Not yet open
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
NCT07014254Pancreatic Ductal Adenocarcinoma (PDAC), Adenocarcinoma of the Stomach, Colorectal Cancer Metastatic, Neuroendocrine Tumor (NET)
Xijing Hospital
Not applicable
20
Xi'an
2025-06-20
Recruiting
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients
NCT06558877Hypertension
Xijing Hospital
Not applicable
1,200
Xi'an
2025-06-20
Recruiting
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
NCT06991257Heart Failure
Pfizer
Phase 2
620
Beijing, Lanzhou, Guangzhou, Haikou, Shijiazhuang, Changsha, Changchun, Xi'an
2025-06-19
Recruiting
Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer
NCT07029269Gastric Adenocarcinoma, Laparoscopic Gastrectomy, Complications
Zuoyi Jiao
Phase 3
454
Beijing, Fuzhou, Lanzhou, Zhejiang, Xi'an
2025-06-16
Not yet open
Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease
NCT07022080Inflammatory Bowel Diseases (IBD)
Xijing Hospital
Not applicable
69
Xi'an
2025-06-15
Recruiting
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
NCT06914440Breast Cancer
Xijing Hospital
Phase 2
27
Xi'an
2025-06-05
Rows per page Showing 101–200 of 504
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 504 of those studies with a site in Xi’an.

How many clinical trials are recruiting in Xi’an?

314 of the 504 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 94 have not yet opened recruitment, 77 are active but closed to new participants, and 19 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.